Emerging therapies, precision tools, and guidelines reshaping oncology

This cluster highlights rapid advances across oncology, from novel immunotherapies and gene-based strategies to smarter drug delivery. Posts span intralesional PD-1 for skin cancer, inhalable gene therapy for lung cancer, engineered macrophages, refined CAR T and T-cell exhaustion strategies, and a new CRISPR platform to pinpoint leukemia drivers. Early detection and treatment are also evolving, with a promising blood test for early pancreatic cancer, innovative antibody–drug conjugate platforms, and combination regimens in breast, bladder, glioblastoma, and renal cancers. Updated ASCO guidelines, equity-focused training programs, and significant funding for head and neck cancer trials underscore how these innovations are being translated into standardized, more accessible care.